Amcinonide NDC 74157-006

NDC codes

FDA NDC Directory

Product NDC (as listed)74157-006Labeler and product segments. Claims need a package NDC.

Product NDC at billing width74157-0006Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
74157-006-60	74157000660	1 TUBE in 1 CARTON (74157-006-60) / 60 g in 1 TUBEMarketed from May 9, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amcinonide
Generic name (nonproprietary): amcinonide
Active ingredients: Amcinonide — 1 mg/g
Dosage form: Cream
Route: Topical
Labeler: INA PHARMACEUTICS INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076229
Marketing start: May 9, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 74157-006_395847bf-ef5e-ef2a-e063-6294a90acf3aSPL ID 395847bf-ef5e-ef2a-e063-6294a90acf3aSPL set ID e7dc754e-eeff-4c30-a52a-629c72ad2415RxCUI 197327UNII 423W026MA9UPC 0374157006605
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N474157000660 followed by a unit qualifier and the quantity

Package 74157-0006-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 7, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)